Research output per year
Research output per year
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Contribution of Real-World Evidence in European Medicines Agency's Regulatory Decision Making
Bakker, E., Plueschke, K., Jonker, C. J., Kurz, X., Starokozhko, V. & Mol, P. G. M., Jan-2023, In: Clinical Pharmacology & Therapeutics. 113, 1, p. 135-151 17 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)12 Downloads (Pure) -
Safety-Related Drug Label Changes Following Large Post-Marketing Cardiometabolic Trials: A Review of European Public Assessment Reports
Starokozhko, V., Tarrahi, F., Vrijlandt, P. J. W. S. & Mol, P. G. M., Apr-2023, In: Clinical Pharmacology and Therapeutics. 113, 4, p. 859-866 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile2 Downloads (Pure) -
Translating Academic Drug Discovery Into Clinical Development: A Survey of the Awareness of Regulatory Support and Requirements Among Stakeholders in Europe
the STARS consortium, Kallio, M. J., Starokozhko, V., Agricola, E., Burggraf, M., Heß, A., Ballensiefen, W., Löbker, W., Nuevo, Y., Pasmooij, A. M. G. & Mol, P. G. M., Feb-2023, In: Clinical Pharmacology and Therapeutics. 113, 2, p. 349-359 11 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile1 Citation (Scopus)5 Downloads (Pure) -
Aandacht voor vrouwen in geneesmiddelenonderzoek
de Vries, S., Vrijlandt, P., Havinga, I. K. & Mol, P. G. M., 1-Apr-2022, In: PiL Praktijkgerichte nascholing over farmacotherapie in de eerste lijn. 12, 1, p. 51-55 5 p.Research output: Contribution to journal › Article › Professional
-
Attention for sex in COVID-19 trials: a review of regulatory dossiers
de Vries, S. T., Starokozhko, V., Schellens, I. M. M., Wijnans, L., Enzmann, H., Cavaleri, M. & Mol, P. G. M., 2022, In: BMJ Global Health. 7, 3, 9 p., 008173.Research output: Contribution to journal › Review article › peer-review
Open AccessFile3 Citations (Scopus)7 Downloads (Pure)
Activities
-
A Selective Approach to Safety Data Collection in Specific Late-Stage Pre-approval or Post-Approval Clinical Trials
Peter Mol (Speaker)
Apr-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
Accelerating Clinical Trials in the EU (ACT EU) (External organisation)
Peter Mol (Member)
2022 → …Activity: Membership › Professional
-
Strengthening Training for Academia in Regulatory Science (STARS) Project: The road so far
Peter Mol (Speaker)
Mar-2022Activity: Talk and presentation › Academic presentation › Academic
-
Hoe regulatoire richtlijnen tot stand komen, een (lang) verhaal
Peter Mol (Speaker)
Jun-2022Activity: Talk and presentation › Professional or public presentation › Professional
-
38th ICPE International Conference on Pharmacoepidemiology
Peter Mol (Organiser)
Aug-2022Activity: Organising and attending an event › Organising and contributing to an event › Academic
Prizes
-
Among the most popular scientific papers in Drug Safety 2019
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2019
Prize: Other distinction › Academic
-
Nomination of Top downloaded paper 2018-2019 in BJCP
de Vries, Sieta (Recipient), Denig, Petra (Recipient), Mol, Peter (Recipient) & van Puijenbroek, Eugène (Recipient), 30-Apr-2019
Prize: Other distinction › Academic
-
Among the most popular scientific papers in Drug Safety 2018
de Vries, Sieta (Recipient), Mol, Peter (Recipient) & Denig, Petra (Recipient), 2018
Prize: Other distinction › Academic
-
Among the most popular publications in Drug Safety in 2017
de Vries, Sieta (Recipient) & Mol, Peter (Recipient), 2017
Prize: Other distinction › Academic